These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17976126)

  • 1. Donor-specific antibodies by flow single antigen beads in pediatric living donor kidney transplants: single center experience.
    Roberti I; Vyas S; Pancoska C
    Pediatr Transplant; 2007 Dec; 11(8):901-5. PubMed ID: 17976126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
    Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
    Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.